Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SHANE R KANNARR

Eye and Vision Services Providers Optometrist

NPI
1891772489
CMS profile
40742
Location
PITTSBURG, KS

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$63,223.61

151 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SHANE R KANNARR

NPI 1891772489 · CMS profile ID 40742

Eye and Vision Services Providers / Optometrist

PITTSBURG, KS

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1891772489?year=2021&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SHANE R KANNARR, NPI 1891772489, CMS profile ID 40742. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1891772489?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). SHANE R KANNARR, NPI 1891772489, CMS profile ID 40742. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1891772489?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
SHANE R KANNARR, NPI 1891772489, CMS profile ID 40742, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1891772489?year=2021&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

151 matching records · $63,223.61 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 151 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 151.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Allergan, Inc. $68.8506/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826671 CMS
Allergan, Inc. $36.0006/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826673 CMS
Allergan, Inc. $1,125.0006/25/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826675 CMS
Allergan, Inc. $19.2006/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826667 CMS
Allergan, Inc. $800.0006/24/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826669 CMS
Kala Pharmaceuticals, Inc. $26.8006/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815672313 CMS
Sight Sciences, Inc. $73.4106/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851134577 CMS
Bausch & Lomb, a division of Bausch Health US, LLC $12.8506/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851226493 CMS
Johnson & Johnson Vision Care, Inc. $17.0005/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 787840583 CMS
Allergan, Inc. $800.0005/12/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826665 CMS
Allergan, Inc. $800.0005/05/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826663 CMS
Allergan, Inc. $29.9805/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826659 CMS
Allergan, Inc. $1,125.0005/04/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826661 CMS
Bausch & Lomb, a division of Bausch Health US, LLC $16.0605/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851226487 CMS
Novartis Pharmaceuticals Corporation $34.4005/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812740983 CMS
Allergan, Inc. $36.6005/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826657 CMS
Allergan, Inc. $29.1704/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826647 CMS
Allergan, Inc. $1,350.0004/30/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826649 CMS
Allergan, Inc. $16.9704/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826651 CMS
Allergan, Inc. $67.0004/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826653 CMS
Allergan, Inc. $1,125.0004/30/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826655 CMS
Johnson & Johnson Vision Care, Inc. $2,000.0004/30/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 989021745 CMS
Novartis Pharmaceuticals Corporation $6.9904/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812740981 CMS
Novartis Pharmaceuticals Corporation $88.7304/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812740985 CMS
Sight Sciences, Inc. $25.6004/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851134581 CMS
Allergan, Inc. $38.8104/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826643 CMS
Allergan, Inc. $42.0504/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826645 CMS
Allergan, Inc. $7.3304/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826639 CMS
Allergan, Inc. $800.0004/28/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826641 CMS
Johnson & Johnson Vision Care, Inc. $500.0004/23/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 989021747 CMS
Allergan, Inc. $1,200.0004/17/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826635 CMS
Allergan, Inc. $29.9804/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826637 CMS
Allergan, Inc. $6.0804/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826633 CMS
Bausch & Lomb, a division of Bausch Health US, LLC $15.1704/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851226491 CMS
Johnson & Johnson Vision Care, Inc. $225.0003/26/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 787840557 CMS
Alcon Vision LLC $17.2703/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797721907 CMS
Johnson & Johnson Vision Care, Inc. $2,000.0003/19/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 989021743 CMS
Allergan, Inc. $800.0003/17/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826631 CMS
Allergan, Inc. $29.9803/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826629 CMS
Alcon Vision LLC $20.1303/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797721917 CMS
Allergan, Inc. $24.6902/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826625 CMS
Allergan, Inc. $1,575.0002/27/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826627 CMS
Allergan, Inc. $148.9602/13/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826623 CMS
Johnson & Johnson Vision Care, Inc. $17.6802/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 787840565 CMS
Allergan, Inc. $1,687.5001/30/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826619 CMS
Allergan, Inc. $29.4301/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826621 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $18.3101/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851929411 CMS
Allergan, Inc. $2,025.0001/01/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826611 CMS
Allergan, Inc. $5,962.5001/01/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826613 CMS
Allergan, Inc. $27.9501/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792826615 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $26,041.68 119
PY2020 $58,115.51 112
PY2021 $63,223.61 151
PY2022 $90,126.44 202
PY2023 $63,166.47 148
PY2024 $71,463.57 171
PY2025 $156,933.75 308

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $690,464.98 187
PY2024 Principal investigator $335,075.37 61
PY2023 Recipient $51,030.00 2
PY2023 Principal investigator $353,478.19 37
PY2022 Principal investigator $608,075.06 219
PY2021 Recipient $22,512.50 1
PY2021 Principal investigator $606,083.65 306
PY2020 Principal investigator $582,322.33 417
PY2019 Recipient $2,500.00 1
PY2019 Principal investigator $689,191.82 213

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

187 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Johnson & Johnson Vision Care, Inc. $27,406.00 12/23/2025 Non-covered Recipient Entity
ADVANTAGE EYE CARE LLC
Clinical evaluation of investigational contact lenses No dispute reported 06/30/2026 1174888453
Principal investigator 1 Johnson & Johnson Vision Care, Inc. $11,850.00 12/23/2025 Non-covered Recipient Entity
ADVANTAGE EYE CARE LLC
Evaluating myopia progression after discontinuation of a soft contact lens for myopia control. No dispute reported 06/30/2026 1174888538
Principal investigator 1 Johnson & Johnson Vision Care, Inc. $1,000.00 12/18/2025 Non-covered Recipient Entity
ADVANTAGE EYE CARE LLC
Clinical evaluation of approved contact lenses No dispute reported 06/30/2026 1174888551
Principal investigator 1 Johnson & Johnson Vision Care, Inc. $8,209.00 12/16/2025 Non-covered Recipient Entity
ADVANTAGE EYE CARE LLC
Clinical evaluation of investigational contact lenses No dispute reported 06/30/2026 1174888430
Principal investigator 1 Oyster Point Pharma, Inc. $2,980.00 12/16/2025 Non-covered Recipient Entity
Kannar Eye Center
Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia (VEGA-3) No dispute reported 06/30/2026 1238522792
Principal investigator 1 Oyster Point Pharma, Inc. $10,936.00 12/12/2025 Non-covered Recipient Entity
Kannar Eye Center
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) No dispute reported 06/30/2026 1238522802
Principal investigator 1 CooperVision Inc. $11,880.00 11/25/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
CV-20-02 No dispute reported 06/30/2026 1243636048
Principal investigator 1 Bausch & Lomb Americas Inc. $14,458.40 11/17/2025 Non-covered Recipient Entity
Kannarr Eye Care, LLC
A Randomized, Multicenter, Double-Masked, Active-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness No dispute reported 06/30/2026 1246979781
Principal investigator 1 Oyster Point Pharma, Inc. $4,390.00 11/17/2025 Non-covered Recipient Entity
Kannar Eye Center
Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia (VEGA-3) No dispute reported 06/30/2026 1238522794
Principal investigator 1 Oyster Point Pharma, Inc. $7,514.00 11/17/2025 Non-covered Recipient Entity
Kannar Eye Center
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) No dispute reported 06/30/2026 1238522800
Principal investigator 1 Johnson & Johnson Vision Care, Inc. $10,437.50 10/21/2025 Non-covered Recipient Entity
ADVANTAGE EYE CARE LLC
Pilot clinical evaluation of investigational contact lenses No dispute reported 06/30/2026 1174888504
Principal investigator 1 Oyster Point Pharma, Inc. $5,018.00 10/15/2025 Non-covered Recipient Entity
Kannar Eye Center
Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia (VEGA-3) No dispute reported 06/30/2026 1238522796
Principal investigator 1 Oyster Point Pharma, Inc. $3,000.00 10/15/2025 Non-covered Recipient Entity
Kannar Eye Center
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) No dispute reported 06/30/2026 1238522798
Principal investigator 1 Oyster Point Pharma, Inc. $5,005.80 10/15/2025 Non-covered Recipient Entity
Kannarr Eye Care
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522820
Principal investigator 1 Oyster Point Pharma, Inc. $11,718.00 10/15/2025 Non-covered Recipient Entity
Kannarr Eye Care
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522822
Principal investigator 1 TOPCON HEALTHCARE, INC. $30,000.00 10/14/2025 Non-covered Recipient Entity
KANNARR EYE CARE
UTILIZATION OF TOPCON EQUIPMENT AND INTERATION TO IMPROVE MEDICAL KPI AND OFFICE EFFICIENCY No dispute reported 06/30/2026 1249770692
Principal investigator 1 Johnson & Johnson Vision Care, Inc. $2,355.00 10/01/2025 Non-covered Recipient Entity
ADVANTAGE EYE CARE LLC
Clinical evaluation of investigational contact lenses No dispute reported 06/30/2026 1174888476
Principal investigator 1 Johnson & Johnson Vision Care, Inc. $14,025.00 09/30/2025 Non-covered Recipient Entity
ADVANTAGE EYE CARE LLC
Evaluating myopia progression after discontinuation of a soft contact lens for myopia control. No dispute reported 06/30/2026 1174888415
Principal investigator 1 Oyster Point Pharma, Inc. $3,262.00 09/30/2025 Non-covered Recipient Entity
Kannar Eye Center
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) No dispute reported 06/30/2026 1238522790
Principal investigator 1 CooperVision Inc. $7,400.00 09/16/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
CV-20-02 No dispute reported 06/30/2026 1243636043
Principal investigator 1 Alcon Research LLC $673.83 08/28/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925499
Principal investigator 1 Alcon Research LLC $673.83 08/28/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925501
Principal investigator 1 Alcon Research LLC $673.83 08/28/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925503
Principal investigator 1 Johnson & Johnson Vision Care, Inc. $29,600.00 08/22/2025 Non-covered Recipient Entity
ADVANTAGE EYE CARE LLC
Pilot clinical evaluation of approved and investigational contact lenses No dispute reported 06/30/2026 1174888442
Principal investigator 1 Oyster Point Pharma, Inc. $6,116.00 08/22/2025 Non-covered Recipient Entity
Kannar Eye Center
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) No dispute reported 06/30/2026 1238522788
Principal investigator 1 Alcon Research LLC $673.83 08/21/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925468
Principal investigator 1 Alcon Research LLC $610.94 08/21/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925470
Principal investigator 1 Alcon Research LLC $620.94 08/21/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925472
Principal investigator 1 Alcon Research LLC $620.94 08/21/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925474
Principal investigator 1 Alcon Research LLC $610.94 08/21/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925476
Principal investigator 1 Alcon Research LLC $673.83 08/21/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925478
Principal investigator 1 Alcon Research LLC $4,000.00 08/21/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925480
Principal investigator 1 Alcon Research LLC $1,000.00 08/21/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925483
Principal investigator 1 Alcon Research LLC $250.00 08/21/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925485
Principal investigator 1 Alcon Research LLC $610.94 08/21/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925487
Principal investigator 1 Alcon Research LLC $1,069.73 08/21/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925489
Principal investigator 1 Alcon Research LLC $512.54 08/21/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925491
Principal investigator 1 Alcon Research LLC $512.54 08/21/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925493
Principal investigator 1 Alcon Research LLC $620.94 08/21/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925495
Principal investigator 1 Alcon Research LLC $512.54 08/21/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925497
Principal investigator 1 Bausch & Lomb Americas Inc. $40,749.60 08/18/2025 Non-covered Recipient Entity
Kannarr Eye Care, LLC
A Randomized, Multicenter, Double-Masked, Active-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness No dispute reported 06/30/2026 1246979778
Principal investigator 1 Oyster Point Pharma, Inc. $9,959.40 08/14/2025 Non-covered Recipient Entity
Kannarr Eye Care
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522816
Principal investigator 1 Oyster Point Pharma, Inc. $7,430.40 08/14/2025 Non-covered Recipient Entity
Kannarr Eye Care
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522818
Principal investigator 1 Alcon Research LLC $512.54 08/07/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925376
Principal investigator 1 Alcon Research LLC $1,069.73 08/07/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925378
Principal investigator 1 Alcon Research LLC $620.94 08/07/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925380
Principal investigator 1 Alcon Research LLC $620.94 08/07/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925382
Principal investigator 1 Alcon Research LLC $673.83 08/07/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925384
Principal investigator 1 Alcon Research LLC $673.83 08/07/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925386
Principal investigator 1 Alcon Research LLC $1,069.73 08/07/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925388
Principal investigator 1 Alcon Research LLC $512.54 08/07/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925390
Principal investigator 1 Alcon Research LLC $673.83 08/07/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925392
Principal investigator 1 Alcon Research LLC $1,069.73 08/07/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925394
Principal investigator 1 Alcon Research LLC $673.83 08/07/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925396
Principal investigator 1 Alcon Research LLC $512.54 08/07/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925398
Principal investigator 1 Alcon Research LLC $620.94 07/31/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925360
Principal investigator 1 Alcon Research LLC $610.94 07/31/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925362
Principal investigator 1 Alcon Research LLC $512.54 07/31/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925364
Principal investigator 1 Alcon Research LLC $610.94 07/31/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925366
Principal investigator 1 Alcon Research LLC $620.94 07/31/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925368
Principal investigator 1 Alcon Research LLC $620.94 07/31/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925370
Principal investigator 1 Alcon Research LLC $512.54 07/31/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925372
Principal investigator 1 Alcon Research LLC $512.54 07/31/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925374
Principal investigator 1 Alcon Research LLC $1.00 07/30/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925166
Principal investigator 1 Alcon Research LLC $6.00 07/28/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925168
Principal investigator 1 Alcon Research LLC $14.40 07/28/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925170
Principal investigator 1 Alcon Research LLC $14.40 07/28/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925172
Principal investigator 1 Alcon Research LLC $14.40 07/28/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925174
Principal investigator 1 Alcon Research LLC $14.40 07/28/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925176
Principal investigator 1 Alcon Research LLC $14.40 07/28/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925178
Principal investigator 1 Alcon Research LLC $14.40 07/28/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925180
Principal investigator 1 Alcon Research LLC $14.40 07/28/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925182
Principal investigator 1 Alcon Research LLC $14.40 07/28/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925184
Principal investigator 1 Alcon Research LLC $14.40 07/28/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925186
Principal investigator 1 Alcon Research LLC $14.40 07/28/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925188
Principal investigator 1 Alcon Research LLC $14.40 07/28/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925190
Principal investigator 1 Alcon Research LLC $14.40 07/28/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925192
Principal investigator 1 Alcon Research LLC $14.40 07/28/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925194
Principal investigator 1 Alcon Research LLC $610.94 07/24/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925350
Principal investigator 1 Alcon Research LLC $610.94 07/24/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925352
Principal investigator 1 Alcon Research LLC $610.94 07/24/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925354
Principal investigator 1 Alcon Research LLC $1,069.73 07/24/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925356
Principal investigator 1 Alcon Research LLC $620.94 07/24/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925358
Principal investigator 1 Oyster Point Pharma, Inc. $3,858.00 07/23/2025 Non-covered Recipient Entity
Kannar Eye Center
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) No dispute reported 06/30/2026 1238522786
Principal investigator 1 Bausch & Lomb Americas Inc. $4,000.00 07/21/2025 Non-covered Recipient Entity
Kannarr Eye Care, LLC
A Randomized, Multicenter, Double-Masked, Active-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness No dispute reported 06/30/2026 1246979770
Principal investigator 1 Bausch & Lomb Americas Inc. $35,084.00 07/21/2025 Non-covered Recipient Entity
Kannarr Eye Care, LLC
A Randomized, Multicenter, Double-Masked, Active-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness No dispute reported 06/30/2026 1246979774
Principal investigator 1 Alcon Research LLC $1,069.73 07/17/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925340
Principal investigator 1 Alcon Research LLC $1,069.73 07/17/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925342
Principal investigator 1 Alcon Research LLC $610.94 07/17/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925344
Principal investigator 1 Alcon Research LLC $1,069.73 07/17/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925346
Principal investigator 1 Alcon Research LLC $1,069.73 07/17/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925348
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925196
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925198
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925200
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925202
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925204
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925206
Principal investigator 1 Alcon Research LLC $1.00 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925208
Principal investigator 1 Alcon Research LLC $6.00 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925210
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925212
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925214
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925216
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925218
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925220
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925222
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925224
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925226
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925228
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925230
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925232
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925234
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925236
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925238
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925240
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925242
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925244
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925246
Principal investigator 1 Alcon Research LLC $14.40 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925248
Principal investigator 1 Alcon Research LLC $1.00 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925250
Principal investigator 1 Alcon Research LLC $6.00 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925252
Principal investigator 1 Alcon Research LLC $1.00 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925254
Principal investigator 1 Alcon Research LLC $6.00 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925256
Principal investigator 1 Alcon Research LLC $1.00 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925258
Principal investigator 1 Alcon Research LLC $6.00 07/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925260
Principal investigator 1 Johnson & Johnson Vision Care, Inc. $13,389.00 06/30/2025 Non-covered Recipient Entity
ADVANTAGE EYE CARE LLC
Evaluating myopia progression after discontinuation of a soft contact lens for myopia control. No dispute reported 06/30/2026 1174888403
Principal investigator 1 Johnson & Johnson Vision Care, Inc. $7,536.00 06/27/2025 Non-covered Recipient Entity
ADVANTAGE EYE CARE LLC
Clinical evaluation of investigational contact lenses No dispute reported 06/30/2026 1174888465
Principal investigator 1 Alcon Research LLC $4,000.00 06/26/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925464
Principal investigator 1 Alcon Research LLC $1,000.00 06/26/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925466
Principal investigator 1 Oyster Point Pharma, Inc. $5,866.00 06/23/2025 Non-covered Recipient Entity
Kannar Eye Center
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) No dispute reported 06/30/2026 1238522778
Principal investigator 1 Alcon Research LLC $16.20 06/20/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925505
Principal investigator 1 Alcon Research LLC $6.00 06/20/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925507
Principal investigator 1 Alcon Research LLC $1.00 06/20/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Evaluation of Soft Contact Lenses No dispute reported 06/30/2026 1220925509
Principal investigator 1 Oyster Point Pharma, Inc. $6,336.00 06/13/2025 Non-covered Recipient Entity
Kannarr Eye Care
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522812
Principal investigator 1 Oyster Point Pharma, Inc. $7,162.00 06/10/2025 Non-covered Recipient Entity
Kannar Eye Center
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) No dispute reported 06/30/2026 1238522784
Principal investigator 1 CooperVision Inc. $2,500.00 05/28/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
CV-20-02 No dispute reported 06/30/2026 1243636039
Principal investigator 1 Johnson & Johnson Vision Care, Inc. $8,964.00 05/09/2025 Non-covered Recipient Entity
ADVANTAGE EYE CARE LLC
Pilot clinical evaluation of approved and investigational contact lenses No dispute reported 06/30/2026 1174888600
Principal investigator 1 Alcon Research LLC $1,923.10 05/08/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925462
Principal investigator 1 Oyster Point Pharma, Inc. $18,884.00 05/06/2025 Non-covered Recipient Entity
Kannar Eye Center
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) No dispute reported 06/30/2026 1238522782
Principal investigator 1 Alcon Research LLC $30.00 05/01/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses No dispute reported 06/30/2026 1220925460
Principal investigator 1 Oyster Point Pharma, Inc. $5,012.00 05/01/2025 Non-covered Recipient Entity
Kannar Eye Center
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) No dispute reported 06/30/2026 1238522776
Principal investigator 1 Oyster Point Pharma, Inc. $4,489.20 04/28/2025 Non-covered Recipient Entity
Kannarr Eye Care
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522810
Principal investigator 1 Oyster Point Pharma, Inc. $10,137.60 04/28/2025 Non-covered Recipient Entity
Kannarr Eye Care
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522814
Principal investigator 1 Johnson & Johnson Vision Care, Inc. $18,169.00 04/14/2025 Non-covered Recipient Entity
ADVANTAGE EYE CARE LLC
Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of WearNCT06749496 No dispute reported 06/30/2026 1174888588
Principal investigator 1 TOPCON HEALTHCARE, INC. $15,000.00 04/11/2025 Non-covered Recipient Entity
KANNARR EYE CARE
UTILIZATION OF TOPCON EQUIPMENT AND INTERATION TO IMPROVE MEDICAL KPI AND OFFICE EFFICIENCY No dispute reported 06/30/2026 1249770690
Principal investigator 1 Alcon Research LLC $2,831.15 04/10/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses No dispute reported 06/30/2026 1220925458
Principal investigator 1 Johnson & Johnson Vision Care, Inc. $2,750.00 04/01/2025 Non-covered Recipient Entity
ADVANTAGE EYE CARE LLC
Clinical evaluation of approved contact lenses No dispute reported 06/30/2026 1174888390
Principal investigator 1 Johnson & Johnson Vision Care, Inc. $1,000.00 04/01/2025 Non-covered Recipient Entity
ADVANTAGE EYE CARE LLC
Clinical evaluation of approved contact lenses No dispute reported 06/30/2026 1174888577
Principal investigator 1 Oyster Point Pharma, Inc. $27,070.00 04/01/2025 Non-covered Recipient Entity
Kannar Eye Center
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) No dispute reported 06/30/2026 1238522780
Principal investigator 1 Johnson & Johnson Vision Care, Inc. $17,046.00 03/27/2025 Non-covered Recipient Entity
ADVANTAGE EYE CARE LLC
Clinical evaluation of investigational contact lenses No dispute reported 06/30/2026 1174888523
Principal investigator 1 Sight Sciences, Inc. $10,637.50 03/20/2025 Non-covered Recipient Entity
Kannarr Eye Care LLC
Prospective Randomized Masked Controlled Trial to Evaluate the Safety and Effectiveness of the TearCare System in the Treatment of the Signs and Symptoms of Dry Eye Disease (SAHARA) No dispute reported 06/30/2026 1244586215
Principal investigator 1 Sight Sciences, Inc. $8,547.30 03/20/2025 Non-covered Recipient Entity
Kannarr Eye Care LLC
Prospective Randomized Masked Controlled Trial to Evaluate the Safety and Effectiveness of the TearCare System in the Treatment of the Signs and Symptoms of Dry Eye Disease (SAHARA) No dispute reported 06/30/2026 1244586219
Principal investigator 1 Oyster Point Pharma, Inc. $14,313.60 03/19/2025 Non-covered Recipient Entity
Kannarr Eye Care
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522808
Principal investigator 1 Alcon Research LLC $1,053.83 02/20/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925448
Principal investigator 1 Alcon Research LLC $1,053.83 02/20/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925450
Principal investigator 1 Alcon Research LLC $1,053.83 02/20/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925452
Principal investigator 1 Alcon Research LLC $1,053.83 02/20/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925454
Principal investigator 1 Alcon Research LLC $1,053.83 02/20/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925456
Principal investigator 1 CooperVision Inc. $3,100.00 02/17/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
CV-20-02 No dispute reported 06/30/2026 1243636053
Principal investigator 1 Alcon Research LLC $1,053.83 02/13/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925446
Principal investigator 1 Oyster Point Pharma, Inc. $15,550.20 02/10/2025 Non-covered Recipient Entity
Kannarr Eye Care
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522806
Principal investigator 1 Alcon Research LLC $1,053.83 02/06/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925412
Principal investigator 1 ABBVIE INC. $7,793.00 02/04/2025 Non-covered Recipient Entity
KANNARR EYE CARE
M23-730 - A Multicenter, Double-masked, Randomized Study to Compare the Efficacy and Safety of the ABBV-444 Tear Formulation with REFRESH OPTIVE Unit Dose in Patients with Dry Eye Disease No dispute reported 06/30/2026 1202443795
Principal investigator 1 Alcon Research LLC $1,053.83 01/30/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925430
Principal investigator 1 Alcon Research LLC $1,053.83 01/30/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925438
Principal investigator 1 Johnson & Johnson Vision Care, Inc. $36,762.75 01/27/2025 Non-covered Recipient Entity
ADVANTAGE EYE CARE LLC
Pilot clinical evaluation of approved and investigational contact lenses No dispute reported 06/30/2026 1174888562
Principal investigator 1 Alcon Research LLC $644.14 01/23/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925400
Principal investigator 1 Alcon Research LLC $831.55 01/23/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925402
Principal investigator 1 Alcon Research LLC $831.55 01/23/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925404
Principal investigator 1 Alcon Research LLC $644.14 01/23/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925406
Principal investigator 1 Alcon Research LLC $644.14 01/23/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925408
Principal investigator 1 Alcon Research LLC $644.14 01/23/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925410
Principal investigator 1 Alcon Research LLC $644.14 01/23/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925428
Principal investigator 1 Johnson & Johnson Vision Care, Inc. $7,354.00 01/21/2025 Non-covered Recipient Entity
ADVANTAGE EYE CARE LLC
Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of WearNCT06749496 No dispute reported 06/30/2026 1174888491
Principal investigator 1 Oyster Point Pharma, Inc. $11,664.00 01/17/2025 Non-covered Recipient Entity
Kannarr Eye Care
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522804
Principal investigator 1 Alcon Research LLC $644.14 01/16/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925422
Principal investigator 1 Alcon Research LLC $1,186.73 01/16/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses No dispute reported 06/30/2026 1220925424
Principal investigator 1 Alcon Research LLC $831.55 01/16/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925426
Principal investigator 1 Alcon Research LLC $831.55 01/16/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925432
Principal investigator 1 Alcon Research LLC $831.55 01/16/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925434
Principal investigator 1 Alcon Research LLC $1,186.73 01/16/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses No dispute reported 06/30/2026 1220925436
Principal investigator 1 Alcon Research LLC $1,186.73 01/09/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses No dispute reported 06/30/2026 1220925414
Principal investigator 1 Alcon Research LLC $831.55 01/09/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925416
Principal investigator 1 Alcon Research LLC $1,053.83 01/09/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925418
Principal investigator 1 Alcon Research LLC $1,053.83 01/09/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925420
Principal investigator 1 Alcon Research LLC $1,053.83 01/09/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925440
Principal investigator 1 Alcon Research LLC $1,053.83 01/09/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925442
Principal investigator 1 Alcon Research LLC $644.14 01/09/2025 Non-covered Recipient Entity
KANNARR EYE CARE LLC
A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease No dispute reported 06/30/2026 1220925444